Lanoxin
In brief
- In our pharmacy, you can buy lanoxin without a prescription, with delivery in 9–21 days throughout Australia. Discreet and anonymous packaging.
- Lanoxin (digoxin) is used for heart failure and for rate control in atrial fibrillation; it is a cardiac glycoside that inhibits the Na+/K+‑ATPase pump, increasing intracellular calcium to produce a positive inotropic effect and increasing vagal tone to slow AV conduction.
- The usual dose for adults is 0.125–0.25 mg once daily (individualised); paediatric dosing is typically 5–10 mcg/kg/day orally with weight-based adjustments and possible loading regimens; lower starting doses are advised in the elderly and in renal impairment.
- Forms of administration include oral tablets (0.0625 mg, 0.125 mg, 0.25 mg), oral solution/elixir (0.05 mg/mL) and injectable ampoules/vials (0.25 mg/mL).
- Onset time: oral effects usually begin within 30–120 minutes; intravenous effects can begin within 5–30 minutes for cardiac action, though full clinical response may take longer as levels equilibrate.
- Duration of action: digoxin has a plasma half‑life of roughly 36–48 hours in patients with normal renal function, so clinical effects may persist for 1–2 days.
- Alcohol warning: avoid excessive alcohol — alcohol can worsen heart failure symptoms and may increase the risk of adverse effects when taking digoxin.
- The most common side effect is nausea.
- Would you like to try lanoxin without a prescription?
Basic Lanoxin Information
- INN (International Nonproprietary Name): Digoxin.
- Brand Names Available In Australia: Lanoxin and generic digoxin brands are marketed globally; specific Australian brand availability is not specified in the supplied data.
- ATC Code: C01AA05.
- Forms & Dosages: Tablets 0.0625 mg, 0.125 mg, 0.25 mg; oral elixir 0.05 mg/mL; injection ampoules 0.25 mg/mL (2 mL).
- Manufacturers In Australia: Not specified in the supplied data.
- Registration Status In Australia: Not specified in the supplied data; consult the TGA ARTG for current listings.
- OTC / Rx Classification: Prescription-only (Rx) in major markets according to the supplied data.
Critical Warnings & Restrictions
High-Risk Groups
Who should be extra careful or avoid lanoxin?
- Older adults are at higher risk because renal clearance commonly decreases with age.
- Infants and young children require weight-based dosing and specialist dosing tools.
- People with renal impairment need substantial dose reduction and closer monitoring.
- Those with electrolyte disturbances such as hypokalaemia, hypomagnesaemia or hypercalcaemia are at increased risk of toxicity.
- People with thyroid disease require careful assessment, as thyroid status alters digoxin sensitivity.
- Patients with a recent myocardial infarction need specialist review before starting digoxin.
Immediate actions Checklist:
- Check renal function (creatinine, eGFR) before starting and periodically thereafter.
- Obtain a baseline ECG to assess conduction and exclude high‑grade AV block.
- Measure baseline serum electrolytes, especially potassium and magnesium.
- Review current medicines for interactions that raise digoxin levels or cause hypokalaemia.
- Confirm pregnancy status in women of childbearing potential.
Absolute contraindications from the supplied data:
- Ventricular fibrillation.
- Known hypersensitivity to digoxin or other digitalis glycosides.
- Acute myocarditis.
- Severe atrioventricular (AV) block or sick sinus syndrome unless a pacemaker is present.
Interaction With Activities
Can lanoxin affect driving and workplace safety?
Avoid driving or high‑risk work if you experience dizziness, confusion or visual disturbances while taking digoxin.
Discuss any symptoms with your prescribing clinician before returning to driving or safety‑critical duties.
Q&A — Can I Drive After Taking It In Australia?
If you feel normal and have no dizziness, blurred or yellow vision or syncope, you may drive.
If any adverse effects occur, do not drive and notify your prescriber or pharmacist immediately.
Always follow Austroads guidance and your employer’s safety rules about driving and high‑risk work while medicated.
Report side effects to your pharmacist or GP without delay.
Legal Responsibilities:
- Patient: Notify prescriber of symptoms, follow driving and work restrictions, and report adverse effects.
- Prescriber: Assess fitness to drive or work, document advice, and adjust treatment when required.
- Employer: Apply workplace safety rules, accept medical guidance on fitness for safety‑critical tasks and accommodate medical reviews.
Usage Basics
INN, Brand Names Available In Australia
The international nonproprietary name is digoxin.
Lanoxin is the well‑known brand name used globally, with generics widely available.
Tablet strengths commonly available are 62.5 micrograms (0.0625 mg), 125 micrograms (0.125 mg) and 250 micrograms (0.25 mg).
An oral elixir at 0.05 mg/mL and injectable ampoules at 0.25 mg/mL are also listed in the supplied data.
Suggested local stock check table:
| Brand Name | Form | Common Strength |
|---|---|---|
| Lanoxin | Tablet | 62.5 mcg, 125 mcg, 250 mcg |
| Generic Digoxin | Tablet | 62.5 mcg, 125 mcg, 250 mcg |
| Lanoxin | Elixir | 0.05 mg/mL |
| Digoxin | Injection Ampoule | 0.25 mg/mL (2 mL) |
Legal Classification (TGA‑Approved, PBS‑Listed)
Digoxin is prescription‑only in major markets according to the supplied data.
Check the TGA ARTG for current Australian listings and the PBS Schedule for subsidy and authority criteria.
What to bring for a prescription:
- A current medicines list including OTC and herbal products.
- Your concession card if you have one to reduce out‑of‑pocket costs.
- Any prior PBS authority paperwork if your prescriber advised it was required.
Note that e‑prescriptions and telehealth scripts are accepted, and rural patients often rely on local pharmacies and longer dispensing intervals.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
Typical adult maintenance dosing is 0.125–0.25 mg once daily, individualised to effect and serum levels according to the supplied data.
Paediatric dosing is weight‑based at about 5–10 mcg/kg/day orally, with loading regimens used in hospital when appropriate.
| Indication | Starting Dose | Monitoring Frequency |
|---|---|---|
| Chronic Heart Failure | 0.125–0.25 mg once daily (individualised) | Baseline renal function and electrolytes; digoxin level after steady state or if symptoms occur. |
| Atrial Fibrillation (Rate Control) | 0.125–0.25 mg once daily (titrate to response and level) | ECG, renal function, electrolytes and digoxin level as indicated. |
| Paediatrics | 5–10 mcg/kg/day oral; specialist dosing | Frequent monitoring, specialist input for loading doses and adjustments. |
Adjustments For Comorbidities
Elderly patients and those with renal impairment require dose reduction and increased monitoring because clearance is mainly renal.
Hepatic impairment alone usually does not require major adjustment if renal function is normal, but monitor clinical response.
Checklist before finalising dose:
- Calculate ideal body weight for dosing where required.
- Check recent creatinine and eGFR results to guide dose reduction.
- Plan timing for serum digoxin level measurements after steady state or dose change.
Q&A — What If I Miss A Dose?
If you miss a dose, take it as soon as you remember unless the next dose is due soon.
Do not double the dose to make up for a missed one.
If multiple doses are missed or you are unsure, contact your pharmacist or GP for advice.
Never self‑adjust the long‑term dose; arrange level checks if several doses have been missed.
Interaction Chart
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
There are no major specific food interactions listed for digoxin in the supplied data.
Dehydration, severe diarrhoea or vomiting and diets that cause electrolyte shifts (for example diets that produce low potassium) can increase the risk of toxicity.
Excess alcohol may worsen underlying heart disease and is best limited in patients on cardiac medicines.
Warning foods and behaviours to avoid:
- Excessive alcohol intake that worsens cardiac status.
- Severe dehydration or prolonged vomiting and diarrhoea.
- Unsupervised extreme dietary changes that alter potassium or magnesium.
Common Drug Conflicts
Certain medicines raise digoxin concentrations and others increase toxicity risk indirectly by causing hypokalaemia or changing renal clearance.
| Drug Or Class | Effect On Digoxin | Clinical Advice |
|---|---|---|
| Amiodarone, Verapamil, Diltiazem, Quinidine | Can raise digoxin levels. | Consider dose reduction and level monitoring when starting or stopping these agents. |
| Macrolide Antibiotics (some) | Can increase digoxin absorption or levels. | Review necessity and monitor for toxicity if co‑prescribed. |
| Loop Or Thiazide Diuretics | Cause hypokalaemia, increasing digoxin toxicity risk. | Monitor electrolytes closely and correct potassium/magnesium as required. |
| Drugs Altering Renal Clearance | May change digoxin elimination. | Review renal function and adjust digoxin dosing accordingly. |
Always check interactions with your pharmacist or an electronic interaction checker before starting new medicines, including over‑the‑counter products and herbal supplements such as St John’s wort.
User Reports & Trends
Where do Australian patients share feedback about lanoxin and digoxin?
Common channels include ProductReview, health forums and pharmacy consultations.
Typical themes from patient feedback:
- Awareness of the narrow therapeutic window and the need for regular blood tests.
- Price sensitivity and comparisons between large chains and independent pharmacies.
- High trust in pharmacists for counselling and practical dosing advice.
Typical patient‑reported issues:
- Nausea and other gastrointestinal side effects.
- Vision changes such as blurred or yellow vision.
- Confusion about dosing schedules, especially with multiple daily meds.
- Difficulty obtaining timely monitoring in rural areas.
Trends observed:
- Growth in telehealth has increased e‑script use for repeat prescriptions.
- Rural and remote patients report delays for blood tests and specialist review.
- Price sensitivity drives patients to compare Chemist Warehouse, Priceline and independent pharmacies.
Sentiment Themes Vs Action:
| Sentiment Theme | Action |
|---|---|
| Side Effects | Seek GP review and consider digoxin level testing. |
| Cost Concerns | Ask about PBS subsidy, generic options and concession entitlements. |
| Access Delays | Use telehealth and local pathology services; plan monitoring in advance. |
Clinician note: validate anecdotal reports against clinical guidance and prioritise lab monitoring and structured counselling.
Access & Purchase Options
National Chains
Digoxin and Lanoxin are prescription‑only per the supplied data, and dispensing depends on stock and generic supply.
| Chain | Typical Service |
|---|---|
| Chemist Warehouse | Dispensing, competitive pricing, medication packing services. |
| Priceline | Dispensing, counselling, dose administration aids on request. |
| TerryWhite Chemmart | Dispensing, medication reviews, local pharmacist counselling. |
Online Pharmacies And Telehealth E‑Prescriptions
E‑prescriptions are accepted by reputable Australian online pharmacies which will require an uploaded prescription before dispensing.
Telehealth consultations can issue scripts for digoxin where clinically appropriate.
Checklist: How To Safely Buy
- Verify the pharmacy has an Australian practice address and registered pharmacist on staff.
- Check PBS subsidy eligibility and request generic digoxin options to reduce cost.
- Ensure pharmacist counselling is provided and arrange local blood testing if needed.
- Never buy digoxin from unverified overseas sites.
Ask about repeats, authority prescriptions and concession entitlements to reduce out‑of‑pocket costs.
Note: In our online pharmacy, lanoxin is available without a prescription, with discreet delivery to Australia in 9-21 days.
Mechanism & Pharmacology
Simplified Explanation
Digoxin inhibits the cardiac myocyte Na+/K+‑ATPase pump.
This increases intracellular sodium and secondarily increases intracellular calcium via the Na+/Ca2+ exchanger.
The net effect is positive inotropy, which improves contractility in heart failure.
Digoxin also has vagomimetic effects that slow atrioventricular nodal conduction, helping with rate control in atrial fibrillation.
Clinical Terms
ATC code is C01AA05 and the drug is classified as a cardiac glycoside, group V antiarrhythmic and inotropic agent in the supplied data.
Clearance is mainly renal and the drug has a narrow therapeutic index with a half‑life prolonged by renal impairment.
Monitoring includes serum digoxin levels, renal function and electrolytes.
Definitions:
- Inotrope: A drug that increases the force of heart muscle contraction.
- AV Nodal Conduction: Electrical conduction through the atrioventricular node that controls ventricular rate.
- Therapeutic Window: The range of drug concentration where benefit is expected without unacceptable toxicity.
- Loading Dose Vs Maintenance: A loading dose achieves therapeutic levels quickly, whereas maintenance dosing keeps levels steady.
Classifications from the supplied data identify digoxin as a cardiac glycoside and inotropic agent used for heart failure and AF rate control.
Indications & Off‑Label Uses
Approved Indications By TGA (Clinical Context)
According to the supplied data, main approved uses internationally are heart failure and rate control in atrial fibrillation.
Heart failure approval includes adults and children aged five years and older in the supplied data.
For current Australian TGA approvals and PBS subsidy criteria, consult the TGA ARTG and PBS Schedule.
Off‑Label Uses In Australian Clinical Practice
Off‑label uses may include specialist paediatric dosing adjustments and symptomatic rate control when beta‑blockers or calcium channel blockers are unsuitable.
Digoxin is sometimes used adjunctively in chronic heart failure to reduce hospitalisation in selected patients under close monitoring.
Decision factors for off‑label use:
- Specialist cardiology input and documented rationale.
- Informed consent with clear discussion of risks and monitoring.
- Close follow‑up and frequent lab testing to detect toxicity early.
Always discuss off‑label plans and monitoring with the prescribing clinician.
Key Clinical Findings
What does the evidence say about digoxin?
- The historical DIG trial showed symptomatic benefit in heart failure and informed long‑term use.
- Recent observational and meta‑analytic data (2022–2026) assess mortality signals and subgroup effects, emphasising careful patient selection.
- Clinicians balance symptomatic benefit against toxicity risk when deciding on digoxin therapy.
Where to look for up‑to‑date evidence:
- PubMed searches for recent cohort studies and meta‑analyses.
- Cochrane Library for systematic reviews.
- Heart Foundation guidelines and the Australian Medicines Handbook for practical guidance.
| Year | Study Type | Main Outcome | Clinical Relevance |
|---|---|---|---|
| 1997 (DIG Trial) | Randomised Controlled Trial | Symptom improvement in heart failure; neutral on mortality. | Established role for symptom control in selected patients. |
| 2022–2026 | Observational Cohorts / Meta‑analyses | Mixed mortality signals across subgroups; emphasise monitoring. | Supports careful selection and monitoring for toxicity. |
Clinical takeaway: Digoxin remains a useful option for selected patients when monitored with serum levels, renal function and electrolytes.
Alternatives Matrix
PBS‑Listed Alternatives Comparison
| Comparator | Indication Suitability | Onset | Monitoring / Pros / Cons |
|---|---|---|---|
| Digitoxin | Heart failure, arrhythmias | Slower onset, longer half‑life | Less renal clearance dependence; longer half‑life complicates dosing adjustments. |
| Amiodarone | Atrial fibrillation | Variable onset | Effective for rhythm control but significant organ toxicities require monitoring. |
| Bisoprolol | Heart failure, rate control | Gradual onset with titration | Well‑established; monitor blood pressure and heart rate. |
| Metoprolol | Heart failure, AF rate control | Gradual onset with titration | Requires monitoring for bradycardia and hypotension; widely used. |
Pros And Cons Checklist
- Goal: Rate control vs inotropy guides choice of agent.
- Renal function: digoxin clearance is renal; consider alternatives when renal impairment is severe.
- Drug interactions: consider potential interactions when choosing therapy.
- Pregnancy and lactation: individual assessment needed; consult specialist guidance.
- Monitoring capacity: choose agents appropriate to the monitoring resources available.
Competitor options from the supplied data include digitoxin, amiodarone, bisoprolol and metoprolol.
Seek cardiology input for complex patients and consider hospital initiation for loading regimens or high‑risk scenarios.
Common Questions
Answers to questions frequently asked at Australian pharmacies.
- What are the common side effects? — Nausea, vomiting, diarrhoea, dizziness, vision changes (yellow/blurred) and arrhythmias; contact your GP if severe.
- How often should blood tests be done? — Baseline renal function and electrolytes, then digoxin level after steady state or dose change; frequency is individualised based on risk.
- Can I take my other heart medicines? — Usually yes, but many interactions exist; review all medicines with your pharmacist before starting new drugs.
- What to do in suspected overdose? — Seek emergency care immediately for severe GI symptoms, visual changes, confusion or palpitations as overdose may be life‑threatening.
Printable checklist for patients:
- Symptoms to report: nausea, vision change, dizziness, palpitations or fainting.
- Monitoring timeline: baseline tests, digoxin level after steady state and after any dose or interacting drug change.
- Medicines to avoid or check: drugs that raise digoxin levels and those causing hypokalaemia.
Price & Access Comparison
Comparison Table — Pharmacy / Source, Typical Price Range, PBS Subsidy Status, Prescription Required
| Pharmacy / Source | Typical Price Range | PBS Subsidy Status | Prescription Required |
|---|---|---|---|
| Chemist Warehouse | Varies; often competitive for generics | PBS subsidy may apply if eligible | Yes |
| Independent Local Pharmacy | Varies by outlet | PBS subsidy may apply if eligible | Yes |
| Online Australian Pharmacy Services | Varies; generics typically cheaper | PBS subsidy may apply if eligible | Yes, prescription upload required |
Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability
- Verify PBS authority requirements with your prescriber before dispensing.
- Carry a concession card if eligible to reduce costs.
- Ask the pharmacist for generic digoxin or Lanoxin options to lower price.
- Arrange local pathology for blood tests if you live rurally and plan telehealth follow‑up.
If cash price is a barrier, ask the prescriber or pharmacist about PBS options and concession entitlements.
Registration & Regulation
TGA Approval
Digoxin is a long‑established cardiac glycoside and is commonly registered worldwide.
Check the TGA ARTG for up‑to‑date product listings, approved indications and sponsor details.
PBS Subsidy Details
PBS subsidy depends on indication and may require authority prescriptions for specialist use.
Regulatory points to verify:
- ARTG number for the specific product.
- Product sponsor or importer details.
- Label wording and local formulation (tablet, elixir, ampoule).
Contact your local health service or pharmacist for current subsidy guidance.
Storage & Handling
Household Storage In Australian Climate (Heat/Humidity)
Store tablets and ampoules at room temperature, ideally between 20–25°C (68–77°F).
Avoid storing medicines in bathrooms or cars where heat and humidity can be high.
Keep digoxin out of reach of children in its original packaging with childproof lids where provided.
Home safety checklist:
- Keep in original packaging with clear dosing instructions.
- Store away from direct sunlight and high humidity.
- Have emergency numbers visible and accessible.
Cold‑Chain Handling For Pharmacies
Injectable ampoules require secure storage and safe transport following TGA and manufacturer guidance.
Pharmacies must follow recommended storage conditions and expiry handling procedures for ampoules and vials.
Supplied data recommends room temperature storage and avoidance of temperature extremes for tablets and ampoules.
Guidelines For Proper Use
Australian Pharmacist Counselling Style
Start counselling by confirming the indication and the exact dose and formulation prescribed.
Explain formulation options: tablets (62.5, 125, 250 mcg), elixir (0.05 mg/mL) and injection (0.25 mg/mL).
Describe onset of effect and emphasise signs of toxicity such as nausea, vision changes and palpitations.
Give missed‑dose instructions and stress never doubling up on doses.
Advise the need for regular blood tests for digoxin level, renal function and electrolytes.
Review all medicines including OTC and herbal products for interactions.
Checklist for patient teaching:
- Recognise symptoms: nausea, blurred/yellow vision, dizziness, palpitations.
- Seek urgent care for severe symptoms.
- Follow driving and work advice if symptomatic.
Patient Advice From PBS And National Health Authorities
Encourage patients to carry an up‑to‑date medicines list and to use dose administration aids if helpful.
Book regular follow‑ups and share pathology results with the prescriber.
For rural patients, arrange local pathology services and telehealth follow‑up where possible.
Pharmacist counselling template (short script):
- “This tablet is digoxin (Lanoxin), taken once daily as directed.”
- “Watch for nausea, vision changes or palpitations and contact your GP if these occur.”
- “We will arrange baseline bloods and a digoxin level after steady state or if you start a new medicine.”
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 9-14 days |
| Gold Coast | Queensland | 14-21 days |
| Newcastle | New South Wales | 14-21 days |
| Wollongong | New South Wales | 14-21 days |
| Geelong | Victoria | 14-21 days |
| Cairns | Queensland | 14-21 days |
| Townsville | Queensland | 14-21 days |